ArticleThe Journal of clinical investigation2022

Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1.

Senem Aykul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.